Today, Julien Gaudias, Senior Director Regulatory Affairs, and David Berner, Associate Director Regulatory Affairs at SFL, a Veristat company, will join Veristat colleagues Mara Holinger, Vice President Regulatory Affairs, and Ellen Truitt, Regulatory Affairs Strategist, to speak about “Orphan Drug Designation – The Considerations, The Rewards, and How They Differ Between The US and Europe”. The webcast will be held on Wednesday, 26 October 2022 from 7:00 – 8:00 PM CET (1:00 PM – 2:00 PM ET). To learn more and register for free, please visit Veristat website or the RAPS website.